| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Hyep Ivan serves as a Chief Financial Officer at BCAX. Across recent SEC filings that breaks down to 0 buys and 17 sells. Those positions are worth an estimated $492K at current prices.
Historically, Hyep Ivan's trades have earned a middling insider score of 62/100 across 7 rated trades. On a 3-month view, 85.7% of the rated trades came out ahead, averaging +9.3% over three months.
The biggest single holding is BCAX (~$492K) as Chief Financial Officer. The recent filings there lean toward selling, a net 150,900 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE10b5-1 | 12,500 | $27.97 | $349,591.25 | -8.8% | - | - | |
| Jul 8, 2026 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE10b5-1 | 28,000 | $28.85 | $807,671.96 | -17.7% | -42.9% | - | |
| May 21, 2026 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE10b5-1 | 9,200 | $20.42 | $187,883.32 | -6.0% | +24.1% | - | |
| Apr 21, 2026 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE10b5-1 | 9,200 | $23.00 | $211,613.80 | -6.0% | +17.5% | - | |
| Mar 23, 2026 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE10b5-1 | 9,200 | $18.52 | $170,348.12 | -6.0% | +33.5% | - | |
| Mar 4, 2026 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE10b5-1 | 16,518 | $18.22 | $300,971.46 | -10.2% | +5.9% | - | |
| Jan 22, 2026 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE10b5-1 | 1,882 | $18.15 | $34,162.44 | -1.3% | +34.3% | - | |
| Dec 22, 2025 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE10b5-1 | 9,200 | $18.31 | $168,491.56 | -6.0% | +0.4% | - | |
| Nov 24, 2025 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE10b5-1 | 18,400 | $18.54 | $341,074.44 | -11.2% | -13.1% | - | |
| Oct 9, 2025 | BCAX Bicara Therapeutics Inc. | Chief Financial Officer | Sale+OE10b5-1 | 6,415 | $18.23 | $116,931.34 | -4.2% | -6.0% | -4.2% |